Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9424 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9424 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9371 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9371 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9357 |
High Similarity |
NPD1549 |
Phase 2 |
0.9195 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9184 |
High Similarity |
NPD4380 |
Phase 2 |
0.9128 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9122 |
High Similarity |
NPD7411 |
Suspended |
0.9078 |
High Similarity |
NPD2796 |
Approved |
0.9007 |
High Similarity |
NPD1510 |
Phase 2 |
0.8947 |
High Similarity |
NPD7075 |
Discontinued |
0.8874 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8857 |
High Similarity |
NPD1240 |
Approved |
0.8824 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8808 |
High Similarity |
NPD1934 |
Approved |
0.8808 |
High Similarity |
NPD6801 |
Discontinued |
0.875 |
High Similarity |
NPD7819 |
Suspended |
0.8732 |
High Similarity |
NPD1607 |
Approved |
0.8679 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8654 |
High Similarity |
NPD6959 |
Discontinued |
0.8608 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8523 |
High Similarity |
NPD1511 |
Approved |
0.8523 |
High Similarity |
NPD6799 |
Approved |
0.8516 |
High Similarity |
NPD7768 |
Phase 2 |
0.8506 |
High Similarity |
NPD2801 |
Approved |
0.8503 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8491 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8491 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8491 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8446 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8411 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8355 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8354 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8344 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8322 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8282 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8282 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.828 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8255 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8232 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8224 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8219 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8217 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8165 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8151 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8151 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8133 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8117 |
Intermediate Similarity |
NPD920 |
Approved |
0.8108 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.8108 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8092 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8071 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8056 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8054 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8024 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7987 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7987 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7977 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7977 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7961 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7933 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7914 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7914 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7879 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7847 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7843 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7823 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7817 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7808 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD919 |
Approved |
0.7727 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7692 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7673 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7671 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7655 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7636 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7635 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7632 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7627 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD943 |
Approved |
0.7596 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7562 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7529 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7412 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7363 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7345 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7341 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7237 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7205 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7205 |
Intermediate Similarity |
NPD4661 |
Approved |
0.72 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7169 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD6273 |
Approved |
0.716 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7151
|
Intermediate Similarity |
NPD7696 |
Phase 3 |